Evidence map›Paper›PMID 35532954›Full record

ArticleJournal of diabetes investigation2022

Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.

Tatsuhiko Urakami, Hiroki Terada, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Yasuko Shoji, Junichi Suzuki, Ichiro Morioka

Abstract read
In one paragraph

Article in Journal of diabetes investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tatsuhiko UrakamiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7976-9557
Hiroki TeradaDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Kei YoshidaDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9554-4956
Remi KuwabaraDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Yusuke MineDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2955-6040
Masako AokiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Yasuko ShojiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Junichi SuzukiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9514-1145
Ichiro MoriokaDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.

Funding

AbbVie LLCAtom Medical Corp.Eli Lilly JapanJCR Pharmaceuticals Co., Ltd.MSD Co., Ltd.Novo Nordisk Pharma Ltd.Terumo Corp.
6 · The paper itself

Abstract

AIMS/

introductionThe aim of the study was to compare two continuous glucose monitoring (CGM) systems, intermittently scanned CGM (isCGM) and real-time CGM (rtCGM), to determine which system achieved better glycemic control in pediatric patients. MATERIALS AND

methodsWe carried out a retrospective cohort study of children and adolescents with type 1 diabetes, and compared the time in range (70-180 mg/dL), time below range (<70 mg/dL) and time above range (>180 mg/dL), and estimated glycated hemoglobin levels between patients on isCGM and rtCGM.

resultsOf the 112 participants, 76 (67.9%) used isCGM and 36 (32.1%) used rtCGM for glycemic management. Patients on rtCGM had significantly greater time in range (57.7 ± 12.3% vs 52.3 ± 12.3%, P = 0.0368), and had significantly lower time below range (4.3 ± 2.7% vs 10.2% ± 5.4%, P < 0.001) than those on isCGM, but there was no significant difference in the time above range (37.4 ± 12.9% vs 38.0% ± 12.5%, P = 0.881) or the glycosylated hemoglobin A1c levels (7.4 ± 0.9% vs 7.5 ± 0.8%, P = 0.734) between the two groups.

conclusionsPediatric patients with type 1 diabetes on rtCGM also showed more beneficial effects for increase of time in range, with a notable reduction of time below range compared with those on isCGM. Real-time CGM might provide better glycemic control than isCGM in children with type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1AdolescentBlood GlucoseBlood Glucose Self-MonitoringChildGlycated HemoglobinHumansHypoglycemic AgentsRetrospective StudiesBlood GlucoseGlycated HemoglobinHypoglycemic AgentsContinuous glucose monitoringHypoglycemiaType 1 diabetes

Identifiers

PMID35532954
PMCPMC9533045

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.